DAVID S CRESSY JR. D.O.
Prescription History 1437108321
Internal Medicine - Pulmonary Disease in Covington, LA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DAVID S CRESSY JR. D.O., an active Pulmonary Disease specialist practicing in Covington, LA. Our medical registry currently tracks 32 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,386 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 250 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other LA PrescribersVs. LA Avg |
|---|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 250 | $893.43 | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 250 Medicare prescriptions for Trelegy Ellipta, about 4.5 times the volume of the typical Louisiana prescriber of this medication (56). Medicare paid an average of $893.43 per fill, versus $820.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 334 30-Day Fills standardized to 30-day supplies 10,020 Days of Medication total across all patients in 2023 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 170 | $40.37▼ below LA avg | ▲ More than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 170 Medicare prescriptions for Albuterol Sulfate Hfa, about 2.8 times the volume of the typical Louisiana prescriber of this medication (60). Medicare paid an average of $40.37 per fill, versus $45.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 223.3 30-Day Fills standardized to 30-day supplies 6,120 Days of Medication total across all patients in 2023 | |||
| Prednisone | 125 | $4.63▼ below LA avg | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 125 Medicare prescriptions for Prednisone, about 2.5 times the volume of the typical Louisiana prescriber of this medication (51). Medicare paid an average of $4.63 per fill, versus $4.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 148 30-Day Fills standardized to 30-day supplies 3,854 Days of Medication total across all patients in 2023 | |||
| SymbicortBudesonide/Formoterol Fumarate | 93 | $411.69▼ below LA avg | ▲ More than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 93 Medicare prescriptions for Symbicort, about 3.3 times the volume of the typical Louisiana prescriber of this medication (28). Medicare paid an average of $411.69 per fill, versus $525.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 99 30-Day Fills standardized to 30-day supplies 2,970 Days of Medication total across all patients in 2023 | |||
| Montelukast Sodium | 86 | $10.84▼ below LA avg | ≈ Typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. In 2023, this provider wrote 86 Medicare prescriptions for Montelukast Sodium, about 1.2 times the volume of the typical Louisiana prescriber of this medication (72). Medicare paid an average of $10.84 per fill, versus $12.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 197 30-Day Fills standardized to 30-day supplies 5,910 Days of Medication total across all patients in 2023 | |||
| Breo ElliptaFluticasone/Vilanterol | 81 | $529.96 | ▲ More than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 81 Medicare prescriptions for Breo Ellipta, about 2.5 times the volume of the typical Louisiana prescriber of this medication (33). Medicare paid an average of $529.96 per fill, versus $513.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 101 30-Day Fills standardized to 30-day supplies 3,030 Days of Medication total across all patients in 2023 | |||
| Fluticasone Propionate | 72 | $12.65▼ below LA avg | ≈ Typical |
About Fluticasone Propionate: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2023, this provider wrote 72 Medicare prescriptions for Fluticasone Propionate, about the same volume as the typical Louisiana prescriber of this medication (63). Medicare paid an average of $12.65 per fill, versus $13.70 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 129 30-Day Fills standardized to 30-day supplies 3,870 Days of Medication total across all patients in 2023 | |||
| Levocetirizine Dihydrochloride | 58 | $6.12▼ below LA avg | ≈ Typical |
About Levocetirizine Dihydrochloride: Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. Show more ▾ It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Levocetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). If your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use levocetirizine in place of your epinephrine. In 2023, this provider wrote 58 Medicare prescriptions for Levocetirizine Dihydrochloride, about 1.2 times the volume of the typical Louisiana prescriber of this medication (47). Medicare paid an average of $6.12 per fill, versus $15.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 76 30-Day Fills standardized to 30-day supplies 2,209 Days of Medication total across all patients in 2023 | |||
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $900.29 | ≈ Typical |
About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma. In 2023, this provider wrote 40 Medicare prescriptions for Breztri Aerosphere, about the same volume as the typical Louisiana prescriber of this medication (36). Medicare paid an average of $900.29 per fill, versus $755.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,620 Days of Medication total across all patients in 2023 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $236.47▼ below LA avg | ▲ More than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 27 Medicare prescriptions for Fluticasone-Salmeterol, about 1.4 times the volume of the typical Louisiana prescriber of this medication (20). Medicare paid an average of $236.47 per fill, versus $238.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| Tadalafil | 26 | $65.93▼ below LA avg | ≈ Typical |
About Tadalafil: Tadalafil is used to treat high blood pressure in the lungs (pulmonary hypertension). Show more ▾ It works by relaxing and widening the blood vessels in your lungs which allows the blood to flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION. In 2023, this provider wrote 26 Medicare prescriptions for Tadalafil, about 84% of the volume of the typical Louisiana prescriber of this medication (31). Medicare paid an average of $65.93 per fill, versus $523.11 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 26 | $776.10 | ≈ Typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2023, this provider wrote 26 Medicare prescriptions for Stiolto Respimat, about 81% of the volume of the typical Louisiana prescriber of this medication (32). Medicare paid an average of $776.10 per fill, versus $632.69 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43 30-Day Fills standardized to 30-day supplies 1,288 Days of Medication total across all patients in 2023 | |||
| Azithromycin | 25 | $6.89▼ below LA avg | ▼ Less than typical |
About Azithromycin: This medication is used to treat certain eye infections. Show more ▾ It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2023, this provider wrote 25 Medicare prescriptions for Azithromycin, about half the volume of the typical Louisiana prescriber of this medication (42). Medicare paid an average of $6.89 per fill, versus $8.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 25.9 30-Day Fills standardized to 30-day supplies 176 Days of Medication total across all patients in 2023 | |||
| Spiriva HandihalerTiotropium Bromide | 24 | $781.54 | ≈ Typical |
About Spiriva Handihaler: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 24 Medicare prescriptions for Spiriva Handihaler, about the same volume as the typical Louisiana prescriber of this medication (21). Medicare paid an average of $781.54 per fill, versus $713.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Zolpidem Tartrate | 22 | $1.43▼ below LA avg | ▼ Less than typical |
About Zolpidem Tartrate: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾ If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA. In 2023, this provider wrote 22 Medicare prescriptions for Zolpidem Tartrate, about a third of the volume of the typical Louisiana prescriber of this medication (56). Medicare paid an average of $1.43 per fill, versus $7.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $674.71 | ▼ Less than typical |
About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2023, this provider wrote 20 Medicare prescriptions for Anoro Ellipta, about 71% of the volume of the typical Louisiana prescriber of this medication (28). Medicare paid an average of $674.71 per fill, versus $562.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| Alprazolam | 19 | $3.14▼ below LA avg | ▼ Less than typical |
About Alprazolam: Alprazolam is used to treat anxiety and panic disorders. Show more ▾ It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA). A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) In 2023, this provider wrote 19 Medicare prescriptions for Alprazolam, about a quarter of the volume of the typical Louisiana prescriber of this medication (93). Medicare paid an average of $3.14 per fill, versus $7.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 19 30-Day Fills standardized to 30-day supplies 347 Days of Medication total across all patients in 2023 | |||
| Trazodone Hcl | 19 | $2.04▼ below LA avg | ▼ Less than typical |
About Trazodone Hcl: This medication is used to treat depression. Show more ▾ It may help to improve your mood, appetite, and energy level as well as decrease anxiety and insomnia related to depression. Trazodone works by helping to restore the balance of a certain natural chemical (serotonin) in the brain. In 2023, this provider wrote 19 Medicare prescriptions for Trazodone Hcl, about a quarter of the volume of the typical Louisiana prescriber of this medication (76). Medicare paid an average of $2.04 per fill, versus $11.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 19 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2023 | |||
| Temazepam | 17 | $7.08▼ below LA avg | ▼ Less than typical |
About Temazepam: This medication is used to treat a certain sleep problem (insomnia). Show more ▾ It may help you fall asleep faster, stay asleep longer, and lessen how often you wake up during the night, so you can get a better night's rest. Temazepam belongs to a class of drugs called benzodiazepines. It acts on your brain to produce a calming effect. Use of this medication is usually limited to short treatment periods of 1 to 2 weeks or less. If your insomnia continues for a longer time, talk to your doctor to see if you need other treatment. A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent. In 2023, this provider wrote 17 Medicare prescriptions for Temazepam, about half the volume of the typical Louisiana prescriber of this medication (33). Medicare paid an average of $7.08 per fill, versus $11.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Wixela InhubFluticasone Propion/Salmeterol | 16 | $132.30▼ below LA avg | ≈ Typical |
About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 16 Medicare prescriptions for Wixela Inhub, about 84% of the volume of the typical Louisiana prescriber of this medication (19). Medicare paid an average of $132.30 per fill, versus $244.73 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 15 | $55.41▼ below LA avg | ≈ Typical |
About Levalbuterol Tartrate Hfa: Levalbuterol is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is a quick-relief drug. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This drug is not approved for use in children younger than 4 years due to increased risk of side effects (such as unusual fast breathing, worsening asthma). Ask your doctor or pharmacist for details. In 2023, this provider wrote 15 Medicare prescriptions for Levalbuterol Tartrate Hfa, about the same volume as the typical Louisiana prescriber of this medication (15). Medicare paid an average of $55.41 per fill, versus $65.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 15 30-Day Fills standardized to 30-day supplies 323 Days of Medication total across all patients in 2023 | |||
| Advair HfaFluticasone Propion/Salmeterol | 15 | $653.15 | ≈ Typical |
About Advair Hfa: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 15 Medicare prescriptions for Advair Hfa, about 75% of the volume of the typical Louisiana prescriber of this medication (20). Medicare paid an average of $653.15 per fill, versus $573.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2023 | |||
| Doxycycline Hyclate | 15 | $9.71▼ below LA avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 15 Medicare prescriptions for Doxycycline Hyclate, about half the volume of the typical Louisiana prescriber of this medication (33). Medicare paid an average of $9.71 per fill, versus $18.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 16 30-Day Fills standardized to 30-day supplies 161 Days of Medication total across all patients in 2023 | |||
| Furosemide | 15 | $4.01▼ below LA avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2023, this provider wrote 15 Medicare prescriptions for Furosemide, about 15% of the volume of the typical Louisiana prescriber of this medication (98). Medicare paid an average of $4.01 per fill, versus $5.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,024 Days of Medication total across all patients in 2023 | |||
| OpsumitMacitentan | 15 | $12,743.59 | ▼ Less than typical |
About Opsumit: Macitentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, which helps decrease the blood pressure in the lungs, and reduces the risk of worsening of symptoms and hospital stays due to the disease. In 2023, this provider wrote 15 Medicare prescriptions for Opsumit, about half the volume of the typical Louisiana prescriber of this medication (30). Medicare paid an average of $12,743.59 per fill, versus $12,111.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| OfevNintedanib Esylate | 15 | $12,652.19 | ▼ Less than typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2023, this provider wrote 15 Medicare prescriptions for Ofev, about half the volume of the typical Louisiana prescriber of this medication (33). Medicare paid an average of $12,652.19 per fill, versus $12,473.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| Incruse ElliptaUmeclidinium Bromide | 15 | $425.51▼ below LA avg | ▼ Less than typical |
About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 15 Medicare prescriptions for Incruse Ellipta, about 71% of the volume of the typical Louisiana prescriber of this medication (21). Medicare paid an average of $425.51 per fill, versus $457.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Ipratropium Bromide | 14 | $31.82▼ below LA avg | ▼ Less than typical |
About Ipratropium Bromide: Ipratropium is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. For preventing symptoms of lung disease, this medication must be used regularly to be effective. Use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) for wheezing or sudden shortness of breath unless otherwise directed by your doctor. Ipratropium does not work as fast as your quick-relief inhaler, but may sometimes be used to relieve symptoms of wheezing or sudden shortness of breath if so prescribed by your doctor. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. In 2023, this provider wrote 14 Medicare prescriptions for Ipratropium Bromide, about a third of the volume of the typical Louisiana prescriber of this medication (40). Medicare paid an average of $31.82 per fill, versus $39.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 16 30-Day Fills standardized to 30-day supplies 417 Days of Medication total across all patients in 2023 | |||
| Prolastin CAlpha-1-Proteinase Inhibitor | 14 | $11,440.21 | ≈ Typical |
About Prolastin C: This medication is used to treat lung problems (emphysema) caused by a certain inherited disease (alpha-1-proteinase inhibitor deficiency). Show more ▾ In people with this condition, lung damage is caused by elastase, a natural substance that the body needs to kill bacteria in the lungs. Normally, a protein (alpha-1-proteinase inhibitor) stops elastase from working when it is no longer needed. However, in people who do not make enough of this protein, elastase does not stop working and damages the lungs. This medication replaces the missing alpha-1-proteinase inhibitor and helps to prevent further lung damage. Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. In 2023, this provider wrote 14 Medicare prescriptions for Prolastin C, about the same volume as the typical Louisiana prescriber of this medication (14). Medicare paid an average of $11,440.21 per fill, versus $11,343.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| Ambrisentan | 13 | $6,990.21 | ▼ Less than typical |
About Ambrisentan: Ambrisentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the lungs, slow the worsening of symptoms, and improve your ability to exercise. In 2023, this provider wrote 13 Medicare prescriptions for Ambrisentan, about half the volume of the typical Louisiana prescriber of this medication (25). Medicare paid an average of $6,990.21 per fill, versus $4,499.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| UptraviSelexipag | 13 | $23,651.34 | ▼ Less than typical |
About Uptravi: Selexipag is used to treat high blood pressure in the lungs (pulmonary arterial hypertension-PAH). Show more ▾ It is used to help slow down worsening of PAH and to decrease the chance of needing treatment in a hospital. Selexipag works by making it easier for blood to flow through the arteries in your lungs. This effect helps increase your ability to exercise. In 2023, this provider wrote 13 Medicare prescriptions for Uptravi, about a third of the volume of the typical Louisiana prescriber of this medication (35). Medicare paid an average of $23,651.34 per fill, versus $20,890.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Clonazepam | 11 | $11.39 | ▼ Less than typical |
About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. In 2023, this provider wrote 11 Medicare prescriptions for Clonazepam, about 17% of the volume of the typical Louisiana prescriber of this medication (65). Medicare paid an average of $11.39 per fill, versus $7.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 307 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DAVID S CRESSY JR. D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Covington, LA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among LA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
